SCHEMBL7418155

SCHEMBL7418155

O=C(CSc1cccc2cccnc12)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.60
ALDH1A1 P00352 8/20 0.60
HPGD P15428 7/20 0.60
HSD17B10 Q99714 5/20 0.60
TP53 P04637 1/20 0.56
HTT P42858 1/20 0.56
MAPT P10636 2/20 0.55
TSHR P16473 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
P2RX7 Q99572 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
PTGES O14684 1/20 0.48
PKM P14618 1/20 0.47
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6093193 0.99 KDM4E (0.59) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL6085357 0.80 ALDH1A1 (0.53) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL1769987 0.77 PTGES (0.57) ALDH1A1HSD17B10TP53HTTMAPT
SCHEMBL2445114 0.76 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL1770115 0.76 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL15219839 0.74 KDM4E (0.75) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL6084644 0.71 ALDH1A1 (0.52) KDM4EALDH1A1P2RX7PTGESLMNA
SCHEMBL6084262 0.70 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL1770138 0.68 ALDH1A1 (0.56) KDM4EALDH1A1MAPTTSHRP2RX7
SCHEMBL6083958 0.68 ALDH1A1 (0.49) KDM4EALDH1A1HPGDHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037878-A2 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 2000-09-27 EP disclosed
WO-1999026927-A2 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 1999-06-03 WO disclosed